NEW YORK (GenomeWeb) – The US Department of Energy's Pacific Northwest National Laboratory and Oregon Health & Science University today announced a collaboration aimed at integrating omics research. 

The organizations have inked a memorandum of understanding to create the OHSU-PNNL Northwest Co-Laboratory for Integrated 'Omics with the goal of investigating disease biomarkers for new drug therapies. The new lab will combine capabilities in genomics, proteomics, and metabolomics research. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.